idarubicin has been researched along with edetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ciarrocchi, G; Lestingi, M; Montecucco, A; Pedrali-Noy, G; Spadari, S | 1 |
| Chwastek, G; Grynkiewicz, G; Gubernator, J; Korycińska, M; Kozubek, A; Lewrick, F; Stasiuk, M; Süss, R | 1 |
1 review(s) available for idarubicin and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for idarubicin and edetic acid
| Article | Year |
|---|---|
Effects of DNA-binding drugs on T4 DNA ligase.
Topics: Adenosine Monophosphate; DNA Ligases; DNA Topoisomerases, Type I; Doxorubicin; Edetic Acid; Ethidium; Idarubicin; Indoles; Intercalating Agents; Polynucleotide Ligases; Substrate Specificity; T-Phages | 1990 |
The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Cholesterol; Chromatography, High Pressure Liquid; Cryoelectron Microscopy; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Drug Storage; Edetic Acid; Humans; Hydrogen-Ion Concentration; Idarubicin; In Vitro Techniques; Liposomes; Male; Mice; Mice, Inbred BALB C; Solubility; Surface Properties | 2010 |